Immunovant, Inc. (IMVT) NASDAQ
30.92
-1.94(-5.90%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
30.92
-1.94(-5.90%)
Currency In USD
| Market Cap | 4.53B |
| Enterprise Value | 3.63B |
| P/E Ratio | -12.46 |
| PEG Ratio | 6.28 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.39 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -10.33 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.53 |
| Return On Equity | -0.68 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -409,000 |
| EBITDA | -532.49M |
| Net Income | -505.61M |
| Diluted EPS | -2.77 |
| Total Cash | 902.11M |
| Total Cash/Share | 4.43 |
| Total Debt | 72,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 9.09 |
| Book Value Per Share | 4.19 |
| 52-Week Change | 100.65 |
| 52-Week High | 36.28 |
| 52-Week Low | 14.32 |
| Moving Average 50 Days | 27.99 |
| Moving Average 200 Days | 23.67 |
| Average Volume | 1.81M |
| Shares Outstanding | 205.31M |
| % Held by Institutions | 60.93 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |